Winfried Siffert Kidney International

Slides:

Advertisements

Similar presentations

Plasma sodium and hypertension

Advertisements

Anemia management in chronic kidney disease

Lipopheresis in the nephrotic syndrome

162. Stability of Polymer/Plasmid DNA Complexes In Vitro and In Vivo

Molecular Therapy Volume 20, Pages S261-S262 (May 2012) DOI: /S (16)

Progression of renal failure and hypertensive nephrosclerosis

John P. Middleton, Patrick H. Pun Kidney International

Gene electrotransfer: Potential for gene therapy of renal diseases

Need for better diabetes treatment for improved renal outcome

Volume 70, Pages S21-S25 (December 2006)

Chimeric RNA/DNA oligonucleotide-based gene therapy

George A. Kaysen, Burl R. Don

Comorbidity and confounding in end-stage renal disease

A new era in phosphate binder therapy: What are the options?

Further evidence for linkage of autosomal-dominant medullary cystic kidney disease on chromosome 1q21 Mari Auranen, Sirpa Ala-Mello, Joni A. Turunen,

Volume 70, Issue 11, Pages (December 2006)

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

The epidemiology of chronic kidney disease

Volume 71, Issue 11, Pages (June 2007)

Edmund G. Lowrie Kidney International

Study of Heart and Renal Protection (SHARP)

Genetic studies into inherited and sporadic hemolytic uremic syndrome

Public health in Africa: What is new—The context, the gains, the losses, the renewed public health, and the way forward D.A.N.C.O. Kaseje, Pamela Juma,

847. Eradication of Therapy-Resistant Human Prostate Tumors Using an Ultrasound Guided Site-Specific Cancer Terminator Virus Delivery Approach Molecular.

660. Bowel/Bladder Sensation and Control in Patients with Spinal Cord Injury Treated with Human Embryonic Stem Cell Therapy Geeta Shroff Molecular Therapy

521. Multiplex Genome Editing of TCR°/CD52 Genes as a Platform for “Off the Shelf” Adoptive T-Cell Immunotherapies Molecular Therapy Volume 22, Pages.

New insights in uremic toxins

Extracorporeal therapy in sepsis: are we there yet?

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

674. Molecular, Biochemical and Biomechanical Analysis of Articular Cartilage Repaired with Genetically Modified Chondrocytes Expressing Insulin-Like.

Microbiology and outcomes of peritonitis in North America

Nephrology in Latin America, with special emphasis on Brazil

AGEs in foods: Do they play a role in uremia?

Molecular Therapy Volume 18, Pages S260-S261 (May 2010) DOI: /S (16)

Genetic determinants of the homocysteine level

Nitric oxide, oxidative stress, and apoptosis

Nephrology Crossword: Glomerulonephritis

Treatment of hyperphosphatemia with sevelamer hydrochloride in dialysis patients: effects on vascular calcification, bone and a close look into the survival.

Volume 73, Pages S72-S75 (April 2008)

Volume 87, Issue 5, Pages (May 2015)

Homocysteine, renal function, and risk of cardiovascular disease

Proteinuria screening for children

Volume 73, Issue 9, Pages (May 2008)

Peritoneal dialysis in Mexico

Taking a public health approach to the prevention of end-stage renal disease: The NKF Singapore Program Sylvia Paz B. Ramirez, Stephen I-Hong Hsu, William.

Phosphate binders on iron basis: A new perspective?

Organ transplantation goes to the movies

Atherosclerotic nephropathy

Volume 72, Issue 2, Pages (July 2007)

Volume 55, Pages S3-S16 (June 1999)

740. Prevention of Radiation-Induced Lung Injury by Administration of Gene-Modified Mesenchymal Stem Cells Molecular Therapy Volume 20, Pages S285-S286.

Volume 83, Issue 4, Pages (April 2013)

Glucose transporter (GLUT1) allele (XbaI–) associated with nephropathy in non-insulin- dependent diabetes mellitus Zhi-Hong Liu, Tian-Jun Guan, Zhao-Hong.

Molecular Therapy Volume 21, Pages S247-S248 (May 2013)

Charles A. Herzog Kidney International

Is complement a target for therapy in renal disease?

Volume 70, Issue 3, Pages (August 2006)

Volume 71, Issue 9, Pages (May 2007)

Volume 70, Issue 5, Pages (September 2006)

Volume 75, Issue 7, Pages (April 2009)

86. A Highly Compact Epitope-Based Marker Suicide Gene for Safer and Easier Adoptive T-Cell Gene Therapy Molecular Therapy Volume 20, Pages S35-S36.

The international realities of live donor kidney transplantation

Relationship between advanced glycoxidation end products, inflammatory markers/acute-phase reactants, and some autoantibodies in chronic hemodialysis.

Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis Karl-Georg Fischer, M.D., Andreas van.

Volume 55, Pages S41-S46 (June 1999)

Morphology of the heart and arteries in renal failure

Daniel L. Roden, Shane T. Grey Kidney International

Asymmetric dimethylarginine: A cardiovascular risk factor in renal disease? Danilo Fliser, Jan T. Kielstein, Hermann Haller, Stefanie M. Bode-Böger Kidney.

Shirley Wong, Roderick A. Slavcev

Presentation transcript:

Cardiovascular pharmacogenetics: On the way toward individually tailored drug therapy Winfried Siffert Kidney International Volume 63, Pages S168-S171 (May 2003) DOI: 10.1046/j.1523-1755.63.s84.38.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Gene structure of GNB3 and haplotypes. Shown are the haplotypes C (associated with the 825C-allele) and T (associated with the 825 T-allele). Exons are numbered. ATG refers to the start codon; TGA refers to the stop codon; and CACA- and CACA+ refer to absence or presence of an intronic insert, respectively. Positions of polymorphisms are given. The shown alleles occur with an almost 100% linkage disequilibrium. Further details in8. Kidney International 2003 63, S168-S171DOI: (10.1046/j.1523-1755.63.s84.38.x) Copyright © 2003 International Society of Nephrology Terms and Conditions